Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.

  • Authors:
    • Qimin He
    • Yongrong Mao
    • Jainping Wu
    • Catrine Decker
    • Malik Merza
    • Naining Wang
    • Staffan Eriksson
    • Juan Castro
    • Sven Skog
  • View Affiliations

  • Published online on: October 1, 2004     https://doi.org/10.3892/ijo.25.4.945
  • Pages: 945-998
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thymidine kinase 1 (TK1), an enzyme involved in the synthesis of precursors for DNA, and thus proliferation dependent, has been suggested as a good tumour marker. We have recently developed poly/monoclonal antibodies against TK1, which proved useful for diagnostics in both serum and immunohistochemistry of cancer patients. The anti-TK1 monoclonal antibodies (mAbs) 1D11 and 1E3 were characterized by Western blot, immunoprecipitation and flow cytometry. TK1 mAbs and Ki-67 mAb were then used for immunohistochemistry staining of tumour sections from 54 patients with ductal infiltrated breast carcinoma. Results showed the relative number of patients with positively stained tumours for TK1 (mAb 1D11) and for Ki-67 (mAb MIB-1) were 47 and 41%, respectively, significantly related (p=0.007). Combination of TK1 mAbs 1D11 and 1E3 increased this number to 56%, due to detection of a significantly higher number of patients with grade 2 tumours. Patients with stage II and grade 2 tumours showed significantly higher TK1 staining when compared to stage I and grade 1. Ki-67 staining was significantly higher in stage III and grade 3. The tumours only stained for TK1 represented higher stages and grades, while tumours staining only for Ki-67 were of lower stages and grades. Combining TK1 and Ki-67 increased the number of patients with positively stained tumours to 69%. In conclusion, TK1 is a reliable marker for identification of patients with grade 2 tumours. The highest number of patients with positively stained tumours were obtained when both TK1 and Ki-67 markers were used.

Related Articles

Journal Cover

October 2004
Volume 25 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
He, Q., Mao, Y., Wu, J., Decker, C., Merza, M., Wang, N. ... Skog, S. (2004). Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.. International Journal of Oncology, 25, 945-998. https://doi.org/10.3892/ijo.25.4.945
MLA
He, Q., Mao, Y., Wu, J., Decker, C., Merza, M., Wang, N., Eriksson, S., Castro, J., Skog, S."Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.". International Journal of Oncology 25.4 (2004): 945-998.
Chicago
He, Q., Mao, Y., Wu, J., Decker, C., Merza, M., Wang, N., Eriksson, S., Castro, J., Skog, S."Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.". International Journal of Oncology 25, no. 4 (2004): 945-998. https://doi.org/10.3892/ijo.25.4.945